Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Terminated 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 3Thoracic 2Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × TP protocol × Thoracic × Clear all
NCT01393080 2016-02-17

NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
160 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01902875 2013-07-18

Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy

Jinling Hospital, China

Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡